Phibro Animal Health Corporation has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 44%. Revenue growth, 3-year annual rate: +16% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Earnings per share, 3-year rate: +44%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 15, FY2012 to FY2026, as filed.

PAHCPhibro Animal Health Corporation

Healthcare

$38.29-3.0% 1Y

$38.29

$28.4052 weeks$59.33

Is it growing?

Excellent

Growing: revenue growing +17% year on year, earnings up +105% year on year, and operating margin widening (+4.4 points).

3 good

Revenue trend+17% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend+105% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+4.4 points operating

Trailing-twelve-month operating margin, 12.8% now against 8.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 82% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PAHC growing?

Phibro Animal Health Corporation has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 44%.

+16%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +16% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +44%
Earnings per share, 3-year rate · revenue +16% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 15
Years of annual history on file · FY2012 to FY2026, as filed